NCT00097240
Completed
N/A
The Raptiva Pregnancy Registry: An Observational Study of the Use and Safety of Raptiva (Efalizumab) During Pregnancy
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Psoriasis
- Sponsor
- Genentech, Inc.
- Enrollment
- 18
- Locations
- 1
- Status
- Completed
- Last Updated
- 15 years ago
Overview
Brief Summary
The Raptiva Pregnancy Registry was a prospective observational study established to obtain data on pregnancy outcomes of women who were exposed to Raptiva.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Study Sites (1)
Loading locations...
Similar Trials
Recruiting
N/A
Study to Compare Maternal, Fetal, and Infant Outcomes of Women With Mild to Moderate Atopic Dermatitis Exposed to Ruxolitinib Cream During Pregnancy With an Unexposed Control PopulationPregnancy RelatedAtopic DermatitisNCT06259669Incyte Corporation958
Completed
N/A
Rebif® Pregnancy RegistryMultiple SclerosisNCT00338741EMD Serono36
Completed
N/A
Pregnancy Exposure Registry for Avonex (Interferon Beta-1a)Prenatal Exposure Delayed EffectsMultiple SclerosisPregnancyNCT00168714Biogen329
Recruiting
N/A
Relugolix Pregnancy Registry: An Observational Study of the Safety of Relugolix-Containing Therapy Exposure in Pregnant Women and Their OffspringPregnancy RelatedPregnancy ComplicationsPregnancy, High RiskNCT05739123Sumitomo Pharma Switzerland GmbH728
Completed
N/A
A Study of Pregnancy and Pregnancy Outcomes in Women With Breast Cancer Treated With Trastuzumab, Pertuzumab in Combination With Trastuzumab, or Ado-Trastuzumab EmtansineBreast CancerPregnancyNCT00833963Genentech, Inc.20